Potential of doripenem for the treatment of infections with multidrug-resistant Pseudomonas spp.
Naesens
R
R
Jansens
H
H
Goossens
H
H
Ieven
M
M
Vlieghe
E
E
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015780:Carbapenems / Q000494:pharmacology* / Q000627:therapeutic use; D000077726:Doripenem; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D007564:Japan; D008826:Microbial Sensitivity Tests; D011549:Pseudomonas / Q000187:drug effects* / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D000077726:Doripenem